Fabrication and characterization of electrospun gelatin-heparin nanofibers as vascular tissue engineering

被引:0
作者
Heyun Wang
Yakai Feng
Zichen Fang
Ruofang Xiao
Wenjie Yuan
Musammir Khan
机构
[1] Shihezi University,School of Chemistry and Chemical Engineering
[2] Tianjin University,School of Chemical Engineering and Technology
[3] Tianjin University-Helmholtz-Zentrum Geesthacht,Joint Laboratory for Bio
来源
Macromolecular Research | 2013年 / 21卷
关键词
gelatin; heparin; electrospinning; crosslinking; nanofibers; vascular tissue engineering;
D O I
暂无
中图分类号
学科分类号
摘要
In this paper, heparin was introduced into electrospun gelatin nanofibrous scaffold for assessment as a controlled delivery device in vascular tissue engineering application. Hybrid gelatin-heparin fibers with smooth surfaces and no bead defects were produced from gelatin solutions with 18% w/v in acetic acid aqueous solution. A significant decrease in fiber diameter was observed when the heparin content was increased from 1 to 5 wt%. The properties of composite gelatin-heparin scaffolds were confirmed by Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC) measurement. The gelatin-heparin fibrous scaffolds were also cross-linked using 1 wt% glutaraldehyde vapor-phase for 7 days. A sustained release of heparin could be achieved from gelatinheparin scaffolds over 14 days. The results of the biocompatibility in vitro tests carried out using human umbilical vein endothelial cells indicated good cell viability and proliferation on the gelatin-heparin scaffolds. The results demonstrated that the use of electrospun gelatin fibers as heparin carriers could be promising for vascular tissue applications. [graphic not available: see fulltext]
引用
收藏
页码:860 / 869
页数:9
相关论文
共 193 条
  • [1] Kenawy E R(2008)undefined Polym. Int. 57 85-undefined
  • [2] Fouad A H(2006)undefined Biomaterials 27 2042-undefined
  • [3] Mohamed E N(2007)undefined Biomacromolecules 8 1116-undefined
  • [4] Raphael M O(2005)undefined Biomacromolecules 6 2017-undefined
  • [5] Luong-Van E(2002)undefined J. Control. Release 81 57-undefined
  • [6] Grøndahl L(2000)undefined Macromolecules 33 3705-undefined
  • [7] Chua K N(1990)undefined Brit. J. Surg. 77 1125-undefined
  • [8] Leong K W(2004)undefined Curr. Opin. Cardiol. 19 589-undefined
  • [9] Victor N(2009)undefined Adv. Drug Deliv. Rev. 61 1020-undefined
  • [10] Cool S M(1998)undefined Macromol. Symp. 127 141-undefined